Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
specialty drugs
Payers
Optum: 3 emerging specialty drugs payers should be watching
Specialty drugs continue to dominate the development pipeline, and a new Optum Rx report spotlights three products that payers should be watching.
Paige Minemyer
Sep 5, 2025 2:55pm
Alternative PBM Navitus enables cost-plus pricing at Costco
Aug 5, 2025 4:25pm
Tombot fetches $6M for robotic pets — Fierce Fundraising Tracker
Jul 2, 2025 12:00pm
Express Scripts controls 89% of PBM market in Michigan: lawsuit
May 2, 2025 4:05pm
Evernorth: Spending growth on GLP-1s outpaces specialty drugs
Mar 25, 2025 6:00am
Waltz Health debuts specialty drug platform to slash costs
Aug 26, 2024 3:20pm